Daniel M Hoefner

Title: The Innovative Contributions of Daniel M. Hoefner

Introduction

Daniel M. Hoefner, an accomplished inventor based in Ashland, Virginia, has made significant strides in the field of biomedical technology. With two patents to his name, he is recognized for his innovative approaches to improving diagnostic methods, particularly in assessing cardiovascular risk and hormonal measurements.

Latest Patents

Hoefner's most recent patents include groundbreaking methodologies that enhance existing testing techniques. One notable patent is for "Lp(a) subform size identification using ELISA". This invention describes methods for determining the particle number and/or molar mass of lipoprotein(a) subforms in biological samples via enzyme-linked immunosorbent assay (ELISA). The technology significantly optimizes lipoprotein ELISA methods, providing devices capable of quantifying Lp(a) particle numbers and population mass efficiently and cost-effectively. It yields a useful diagnostic tool for assessing cardiovascular risk by allowing for rapid and affordable measurement of specific Lp(a) levels in patients.

His second patent, "Method for measurement of bioavailable testosterone", introduces innovative procedures for determining the level of bioactive testosterone in biological samples. This method utilizes the aromatase enzyme to convert free testosterone into estradiol, allowing for precise measurements of testosterone levels before and after enzyme addition. Additionally, it involves using a competitor to displace testosterone bound to sex hormone-binding globulin (SHBG), facilitating accurate reflection of testosterone levels in the sample.

Career Highlights

Throughout his career, Daniel M. Hoefner has contributed to the advancement of medical technology through his work in various companies, including Naviga LLC and True Health IP LLC. His dedication to innovation is evident in the methodologies he has developed, which bridge critical gaps in diagnostics and hormonal assessment.

Collaborations

Daniel has collaborated with talented professionals, including Rebecca Caffrey and Philip A. Guadagno. These collaborations have enriched his inventive process, allowing for the development of technologies that can significantly impact clinical practices.

Conclusion

Daniel M. Hoefner stands out as a prominent inventor whose work impacts the biomedical field by improving diagnostic methods and enhancing patient care. With his invaluable contributions, he continues to pave the way for future innovations in healthcare technologies.